The down-regulatory effect of TULA-1 on NF-κB signaling results in the suppression of IL-2 production by activated T cells, which appears to underlie the biological/pathological effects of TULA-1 type-1 diabetes risk alleles [9,99]. This evidence concerns the gene UBASH3A and type 1 diabetes mellitus.